Guidance for Myriad Genetics Inc. (MYGN)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2013 |
$1.55 – 1.58 |
$1.54 |
$575.00M – 585.00M |
$580.06M |
= Maintained |
Details |
| 2013 |
$1.50 – 1.55 |
$1.47 |
$570.00M – 585.00M |
$563.50M |
 Raised |
Details |
| 2012 |
$1.24 – 1.28 |
$1.24 |
$465.00M – 475.00M |
$461.45M |
Raised |
Details |
| 2012 |
$1.20 – 1.25 |
$1.25 |
$445.00M – 465.00M |
$450.80M |
= Maintained |
Details |
| 2012 |
N/A |
N/A |
$492.00M – 496.00M |
$474.00M |
= Maintained |
Details |
| 2012 |
N/A |
N/A |
$492.00M – 496.00M |
$474.00M |
= Maintained |
Details |
| 2012 |
$1.44 – 1.48 |
$1.30 |
$550.00M – 565.00M |
$494.50M |
= Maintained |
Details |
| 2011 |
$0.95 – 1.00 |
$1.02 |
$380.00M – 400.00M |
$390.91M |
= Maintained |
Details |
| 2011 |
$1.06 – 1.09 |
$1.02 |
$396.00M – 402.00M |
$392.00M |
Raised |
Details |
